Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Aug 1, 2025
United States Steel Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $5.33 thousand as of August 1, 2025. Its market cap has decreased by -99.86% in one year.
Market Cap
5.33K
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 5.33K, a decrease of -99.99%. That is a compound annual growth rate of -75.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 53.00 | -99.01% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | 61.10M | 54.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |